+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Artificial Pulmonary Valve System Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6119443
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The artificial pulmonary valve system market is entering a pivotal stage, shaped by advances in device design, supply chain dynamics, and evolving global healthcare priorities. Senior decision-makers in clinical, operational, and commercial leadership roles require actionable insight to navigate this complex and fast-evolving landscape.

Market Snapshot: Artificial Pulmonary Valve System Market

The Artificial Pulmonary Valve System Market grew from USD 1.38 billion in 2025 to USD 1.54 billion in 2026. It is expected to continue growing at a CAGR of 13.95%, reaching USD 3.45 billion by 2032. The market’s robust expansion is driven by rising procedural volumes, expanding clinical indications, and rapid adoption of both surgical and minimally invasive valve replacement solutions across developed and emerging healthcare systems.

Scope & Segmentation

This report provides a comprehensive overview of the artificial pulmonary valve system market, analyzing regulatory trends, clinical innovation, material science, and supply chain resilience. Key segmentation areas include:

  • Product Types: Surgically implanted valves—including bioprosthetic and mechanical varieties—and transcatheter platforms (balloon-expandable and self-expandable).
  • Material Types: Mechanical, polymer, and tissue-based devices, with further focus on design subtypes and their impact on durability and hemodynamics.
  • End-User Settings: Hospitals, ambulatory surgical centers, and specialty clinics that vary in procedural logistics and patient care protocols.
  • Distribution Channels: Direct sales and distributor-led models, each supporting different commercialization strategies.
  • Patient Age Cohorts: Differentiation between adult (geriatric, middle-aged, young adult) and pediatric populations (adolescent, infant, neonatal), highlighting unique device sizing and management needs.
  • Regional Coverage: Detailed analysis for Americas, EMEA, and Asia-Pacific, reflecting regulatory, infrastructural, and payer-driven dynamics.

Key Takeaways for Decision-Makers

  • Choice between surgically implanted and transcatheter artificial pulmonary valve systems hinges on assessments of anatomy, procedural risk, and long-term durability.
  • Material selection—across mechanical, tissue, and polymer variants—directly affects clinical performance, reintervention rates, and production scalability.
  • Tariff adjustments have triggered supply chain recalibration, prompting increased emphasis on near-shoring, dual-sourcing, and inventory management for device continuity.
  • Integrated commercial models, flexible clinician training, and outcome-based contracting are now critical for achieving clinical adoption and payer alignment.
  • Pediatric and geriatric populations require unique approaches to product design, regulatory strategy, and postmarket support, emphasizing differentiated clinical pathways.
  • Regional differences in payer priorities and healthcare infrastructure shape device uptake and necessitate adaptable go-to-market strategies.

Tariff Impact and Supply Chain Resilience

New tariffs introduced in 2025 have altered global procurement strategies for valve system components and raw materials. Manufacturers have responded by localizing production, dual-sourcing suppliers, and improving supply transparency to manage margin pressures and mitigate risks associated with longer lead times and device availability. Health systems have adapted by diversifying approved vendor lists and considering total landed cost—not just unit price—when making procurement decisions.

Methodology & Data Sources

This analysis uses a mixed-methods research framework blending primary interviews with clinicians, device developers, and procurement specialists, alongside secondary review of peer-reviewed publications, regulatory documents, and procedural databases. Data triangulation and iterative expert validation ensure accuracy and actionable strategic recommendations for stakeholders.

Why This Report Matters

  • Supports informed investment decisions by detailing regulatory trends, clinical evidence generation, and market access strategies.
  • Enables manufacturers and health systems to optimize product development, supply chain agility, and commercial models for evolving market realities.
  • Provides clarity on segmentation, regional adaptation, and downstream operational impacts critical for sustainable growth and competitive differentiation.

Conclusion

The artificial pulmonary valve system market is shaped by intersecting trends in device innovation, regulatory adjustment, and supply chain management. Aligning clinical, operational, and commercial strategies is essential for stakeholders targeting sustainable value and adoption in this dynamic landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Artificial Pulmonary Valve System Market, by Product Type
8.1. Surgically Implanted Pulmonary Valve
8.1.1. Bioprosthetic Valve
8.1.2. Mechanical Valve
8.2. Transcatheter Pulmonary Valve
8.2.1. Balloon Expandable Valve
8.2.2. Self Expandable Valve
9. Artificial Pulmonary Valve System Market, by Material Type
9.1. Mechanical Valve
9.2. Polymer Valve
9.3. Tissue Valve
9.3.1. Pericardial Tissue
9.3.2. Porcine Tissue
10. Artificial Pulmonary Valve System Market, by End User
10.1. Ambulatory Surgical Centers
10.2. Hospitals
10.3. Specialty Clinics
11. Artificial Pulmonary Valve System Market, by Region
11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific
12. Artificial Pulmonary Valve System Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Artificial Pulmonary Valve System Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. United States Artificial Pulmonary Valve System Market
15. China Artificial Pulmonary Valve System Market
16. Competitive Landscape
16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. Abbott Laboratories
16.6. Affluent Medical, Inc.
16.7. Anteris Technologies Pty Ltd
16.8. Artivion, Inc.
16.9. BIOTRONIK SE & Co. KG
16.10. Boston Scientific Corporation
16.11. Braile Biomédica Indústria e Comércio S.A.
16.12. Colibri Heart Valve, LLC
16.13. Corcym S.r.l.
16.14. Edwards Lifesciences Corporation
16.15. Foldax, Inc.
16.16. Innovalve Bio Medical Ltd.
16.17. JenaValve Technology, Inc.
16.18. Labcor Laboratórios Ltda
16.19. Lepu Medical Technology Co., Ltd.
16.20. LivaNova PLC
16.21. Medtronic plc
16.22. Meril Life Sciences Pvt. Ltd.
16.23. MicroPort CardioFlow Medtech Corporation
16.24. Peijia Medical Devices Co., Ltd.
16.25. PolyVascular, Inc.
16.26. TTK Healthcare Limited
16.27. Venus MedTech (Hangzhou) Inc.
16.28. Xeltis NV
List of Figures
FIGURE 1. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BIOPROSTHETIC VALVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BIOPROSTHETIC VALVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BIOPROSTHETIC VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE VALVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE VALVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SELF EXPANDABLE VALVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SELF EXPANDABLE VALVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SELF EXPANDABLE VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MECHANICAL VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY POLYMER VALVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY POLYMER VALVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY POLYMER VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PERICARDIAL TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PERICARDIAL TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PERICARDIAL TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PORCINE TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PORCINE TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PORCINE TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 52. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 53. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 54. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 58. NORTH AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. NORTH AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 60. NORTH AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 61. NORTH AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 62. NORTH AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 65. LATIN AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. LATIN AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 67. LATIN AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 68. LATIN AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 69. LATIN AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 70. LATIN AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. EUROPE ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. EUROPE ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 81. EUROPE ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 82. EUROPE ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 83. EUROPE ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 84. EUROPE ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 85. EUROPE ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. MIDDLE EAST ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. MIDDLE EAST ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. MIDDLE EAST ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 96. AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 97. AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 98. AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 99. AFRICA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. ASEAN ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. ASEAN ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. ASEAN ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 111. ASEAN ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 112. ASEAN ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 113. ASEAN ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 114. ASEAN ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. GCC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GCC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 117. GCC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 118. GCC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 119. GCC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 120. GCC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 121. GCC ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. BRICS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. BRICS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. BRICS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 132. BRICS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 133. BRICS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 134. BRICS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 135. BRICS ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. G7 ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. G7 ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 138. G7 ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 139. G7 ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 140. G7 ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 141. G7 ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 142. G7 ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. NATO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. NATO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. NATO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 146. NATO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 147. NATO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 148. NATO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 149. NATO ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 152. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 154. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 155. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 156. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 157. UNITED STATES ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. CHINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 159. CHINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 160. CHINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY SURGICALLY IMPLANTED PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 161. CHINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TRANSCATHETER PULMONARY VALVE, 2018-2032 (USD MILLION)
TABLE 162. CHINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 163. CHINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY TISSUE VALVE, 2018-2032 (USD MILLION)
TABLE 164. CHINA ARTIFICIAL PULMONARY VALVE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

  • Abbott Laboratories
  • Affluent Medical, Inc.
  • Anteris Technologies Pty Ltd
  • Artivion, Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomédica Indústria e Comércio S.A.
  • Colibri Heart Valve, LLC
  • Corcym S.r.l.
  • Edwards Lifesciences Corporation
  • Foldax, Inc.
  • Innovalve Bio Medical Ltd.
  • JenaValve Technology, Inc.
  • Labcor Laboratórios Ltda
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort CardioFlow Medtech Corporation
  • Peijia Medical Devices Co., Ltd.
  • PolyVascular, Inc.
  • TTK Healthcare Limited
  • Venus MedTech (Hangzhou) Inc.
  • Xeltis NV

Table Information